Company Overview and News

0
Future Lifestyle Fashions Limited - Allotment of Securities

2018-07-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

0
Hathway Cable, Den Networks plunge on Reliance fibre broadband service move

2018-07-05 thehindubusinessline
Shares of broadcasting and cable TV operators tanked up to 15.4 per cent today after Reliance unveiled fiber broadband service in 1,100 cities.
DEN 536507 INFY FLFL 533137

0
Indore Municipal Corp lists bonds on NSE

2018-07-05 thehindubusinessline
Following the footsteps of urban bodies like Hyderabad and Pune, Indore Municipal Corporation (IMC) today listed its bonds on the debt market platform of the National Stock Exchange (NSE).
536507 INFY FLFL

0
Infosys breaks support at Rs 1,325, plummets 5.73%

2018-07-05 thehindubusinessline
Shares of Infosys Ltd fell as much as 5.73 per cent to Rs 1268.1, its biggest daily percentage loss since April 16. The stock was the top drag on the NSE index, which ended down 20.15 points. Over 85,00,00 shares changed hands, more than double the 30-day average volume.
536507 INFY FLFL

0
Movers shakers: Redington India, JK Cement volumes grow the most in last 5 days

2018-07-05 moneycontrol
The market is trading flat this Thursday afternoon with the Nifty up 6 points at 10,776 and the Sensex gaining 4 points at 35,649.
534976 536507 VMART BHAGYNAGAR 532163 SAREGAMA 532967 512296 KIRIINDUS FLFL

0
Maruti Suzuki hits near 3-month high

2018-07-05 thehindubusinessline
Shares of Maruti Suzuki India Ltd gained as much as 1.12 per cent to Rs 9,324.4, their highest since April 11.
536507 MARUTI MRZUY FLFL 532500

0
Shriram Transport Finance shares move up 4%

2018-07-05 thehindubusinessline
Shares of Shriram Transport Finance Co Ltd rose as much as 4.3 per cent to Rs 1,194.35, their biggest intraday percentage gain since April 5. The group firm SVL Ltd has the wherewithal to honour repayment on non-convertible debentures (NCDs) guaranteed by it, STFC said on Wednesday
511218 536507 DB SRRQY SRTRANSFIN FLFL

0
Future Lifestyle Fashions gains 5%

2018-07-05 thehindubusinessline
Shares of Future Lifestyle Fashions rose as much as 5.2 per cent to Rs 420 on Thursday. The company on Wednesday said it would invest about Rs 1,400 crore ($20.35 mln) in online fashion retailer Koovs Plc. This will give the company access to online fashion platform, something that had been missing from its portfolio, according to Jefferies analysts.
536507 FLFL

0
Future Lifestyle to buy 29.9% stake in Koovs for GBP 15.3 mn

2018-07-04 moneycontrol
Future Lifestyle Fashions, part of Kishore Biyani-led Future group, today said it will acquire 29.9 percent stake in London-listed e-commerce fashion firm Koovs for GBP 15.3 million or approximately Rs 140 crore.
536507 FLFL

0
Future Lifestyle Fashions Limited - Outcome of Board Meeting

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

0
Future Lifestyle Fashions Limited - Press Release

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

0
Future Lifestyle Fashions Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

0
Future Lifestyle Fashions Limited - Allotment of Securities

2018-06-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

0
Future Lifestyle Fashions Limited - Shareholders meeting

2018-06-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

0
Future Lifestyle Fashions Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
536507 FLFL

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...